| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/S0079-6123(08)80010-6 |
| P698 | PubMed publication ID | 20302835 |
| P2093 | author name string | Gian Paolo Zara | |
| Maria Rosa Gasco | |||
| Lorenzo Priano | |||
| P2860 | cites work | In vitro and in vivo study of solid lipid nanoparticles loaded with superparamagnetic iron oxide | Q47771192 |
| Transferrin-conjugated solid lipid nanoparticles for enhanced delivery of quinine dihydrochloride to the brain | Q47838302 | ||
| Pharmacokinetics of doxorubicin incorporated in solid lipid nanospheres (SLN). | Q48117281 | ||
| Body distribution of camptothecin solid lipid nanoparticles after oral administration | Q48197933 | ||
| Pharmacokinetics, tissue distribution and bioavailability of nitrendipine solid lipid nanoparticles after intravenous and intraduodenal administration | Q48376807 | ||
| Intravenous administration to rabbits of non-stealth and stealth doxorubicin-loaded solid lipid nanoparticles at increasing concentrations of stealth agent: pharmacokinetics and distribution of doxorubicin in brain and other tissues | Q48520331 | ||
| Assessing sedation with regional anesthesia: inter-rater agreement on a modified Wilson sedation scale. | Q51334243 | ||
| Analysis of plasma protein adsorption on polymeric nanoparticles with different surface characteristics. | Q52996852 | ||
| Absorption of apomorphine by various routes in parkinsonism | Q68016689 | ||
| The human H and T reflex methodologies applied to the rat | Q72433881 | ||
| Biodistribution of stealth and non-stealth solid lipid nanospheres after intravenous administration to rats | Q73112544 | ||
| Cellular uptake and cytotoxicity of solid lipid nanospheres (SLN) incorporating doxorubicin or paclitaxel | Q73408492 | ||
| The absolute bioavailability of oral melatonin | Q73961833 | ||
| Non-stealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin: pharmacokinetics and tissue distribution after i.v. administration to rats | Q74316303 | ||
| Solid lipid nanoparticles in lymph and plasma after duodenal administration to rats | Q74628292 | ||
| Enhancement of experimental allergic encephalomyelitis (EAE) by DNA immunization with myelin proteolipid protein (PLP) plasmid DNA | Q77162060 | ||
| The critical component to establish in vitro BBB model: Pericyte | Q81297596 | ||
| Tight junctions of the blood-brain barrier | Q28145432 | ||
| Challenges and solutions for the delivery of biotech drugs--a review of drug nanocrystal technology and lipid nanoparticles | Q28283289 | ||
| Atovaquone nanosuspensions show excellent therapeutic effect in a new murine model of reactivated toxoplasmosis | Q28365205 | ||
| Nanotechnology approaches for drug and small molecule delivery across the blood brain barrier | Q31095938 | ||
| Iontophoretic delivery of apomorphine. II: An in vivo study in patients with Parkinson's disease. | Q32132635 | ||
| The choroid plexuses and the barriers between the blood and the cerebrospinal fluid | Q33851301 | ||
| Blood-brain barrier permeability to small and large molecules | Q33904234 | ||
| P-Glycoprotein, a gatekeeper in the blood-brain barrier | Q33904245 | ||
| Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. | Q33935309 | ||
| The molecular structure of the tight junction | Q33943468 | ||
| Astrocyte-endothelial interactions and blood-brain barrier permeability | Q33960608 | ||
| A benefit-risk assessment of baclofen in severe spinal spasticity. | Q33981151 | ||
| Pharmacokinetics, tissue distribution and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduodenal administration | Q33988624 | ||
| Drug targeting to the brain. | Q33999344 | ||
| CNS drug design based on principles of blood-brain barrier transport | Q34066442 | ||
| Role of the CNS microvascular pericyte in the blood-brain barrier | Q34067528 | ||
| Progress in understanding the structure-activity relationships of P-glycoprotein | Q34581554 | ||
| A new function for the LDL receptor: transcytosis of LDL across the blood-brain barrier | Q36267668 | ||
| Solid lipid nanoparticles enhance the delivery of the HIV protease inhibitor, atazanavir, by a human brain endothelial cell line | Q39976449 | ||
| Intracellular accumulation and cytotoxicity of doxorubicin with different pharmaceutical formulations in human cancer cell lines | Q40218737 | ||
| Cholesteryl butyrate solid lipid nanoparticles inhibit adhesion of human neutrophils to endothelial cells. | Q41779474 | ||
| Preparation and characterization of solid lipid nanospheres containing paclitaxel | Q43464750 | ||
| Transdermal permeation of apomorphine through hairless mouse skin from microemulsions | Q43726119 | ||
| Incorporation of cyclosporin A in solid lipid nanoparticles (SLN). | Q44052307 | ||
| Duodenal administration of solid lipid nanoparticles loaded with different percentages of tobramycin | Q44415253 | ||
| Nocturnal anomalous movement reduction and sleep microstructure analysis in parkinsonian patients during 1-night transdermal apomorphine treatment | Q44642352 | ||
| Brain uptake of thiamine-coated nanoparticles | Q44673525 | ||
| In situ blood-brain barrier transport of nanoparticles | Q44684307 | ||
| Pharmacokinetics of melatonin in man after intravenous infusion and bolus injection | Q44902476 | ||
| Transdermal apomorphine permeation from microemulsions: a new treatment in Parkinson's disease | Q45010962 | ||
| Melatonin delivery in solid lipid nanoparticles: prevention of cyclosporine A induced cardiac damage | Q46131855 | ||
| Solid lipid nanoparticles incorporating melatonin as new model for sustained oral and transdermal delivery systems | Q46710722 | ||
| P921 | main subject | nanoparticle | Q61231 |
| drug delivery | Q1392806 | ||
| P304 | page(s) | 181-192 | |
| P577 | publication date | 2009-12-08 | |
| P1433 | published in | Progress in Brain Research | Q15800382 |
| P1476 | title | Chapter 10 - Solid lipid nanoparticles and microemulsions for drug delivery The CNS. | |
| P478 | volume | 180 |
| Q44167003 | Biological nanopesticides: a greener approach towards the mosquito vector control |
| Q28483110 | New clathrin-based nanoplatforms for magnetic resonance imaging |
| Q37805491 | Properties, engineering and applications of lipid-based nanoparticle drug-delivery systems: current research and advances |
| Q48893237 | The physics of drug-delivery across the blood-brain barrier. |
Search more.